Weekly Digest – July 2026 Weekly Digest – July 2026 17 July 2026: Biokin Pharma announces approval of Iza-bren in China for the treatment of recurrent/metastatic ESCC Biokin Pharma announced that China’s NMPA has approved Iza-bren for the treatment of […]
Weekly Digest – July 2026 Weekly Digest – July 2026 17 July 2026: NMPA accepts New Drug Application for Trastuzumab Envedotin injection CSPC Pharmaceutical Group announced that China’s NMPA has accepted the new drug application for Trastuzumab envedotin injection, a […]
Weekly Digest – July 2026 Weekly Digest – July 2026 18 July 2026: Medilink announces NMPA acceptance of marketing application for Tam-Peli in 3L+ NPC MediLink Therapeutics announced that China’s NMPA has accepted the new drug application for Tam-Peli, its […]
Weekly Digest – July 2026 Weekly Digest – July 2026 21 July 2026: SEC recommends approval to Enhertu for two additional indications in India India’s Subject Expert Committee has recommended approval of two additional indications for AstraZeneca and Daiichi Sankyo’s […]
Weekly Digest – July 2026 Weekly Digest – July 2026 21 July 2026: Telix doses first patient in phase 3 LUTEON trial of TLX250-Tx for Renal cancer Telix Pharmaceuticals announced the first patient dosing in the pivotal phase 3 LUTEON […]
Weekly Digest – July 2026 Weekly Digest – July 2026 22 July 2026: Samsung Bioepis enters into a commercial license agreement with IntoCell for an ADC candidate Samsung Bioepis has entered into a commercial license agreement with IntoCell for SBE303, […]
